S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT‐POSITIVE ACUTE MYELOID LEUKAEMIA
Dokal, Arran, Borek, Weronika E., Nobre, Luis, Federico Pedicona, Salvatore, Wrench, Bela, Gallipoli, Paolo, Arruda, Andrea, Campbell, Amy E., Nawaz, Nazrath, Ferguson, Harriet R., Perkins, David N., Moreno‐Cardoso, Pedro, Thompson, Andrew, Williamson, Andrew J.K., Minden, Mark D., Gribben, John G., Britton, David J., Cutillas, Pedro R.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia
Veiga Nobre, Luis Miguel Veiga, Pedicona, Salvatore Federico, Dokal, Arran, Arruda, Andrea, Smith, Ryan, Greenhalgh, Calum, Patella, Francesca, Casado-Izquierdo, Pedro, Wrench, Bela, Theaker, Jane, Thompson, Andrew, Minden, Mark D., Gribben, John G., Britton, David James, Cutillas, Pedro
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Abstract LBA013: Phosphoproteomics reveals active drug targets on pathways of resistance and predicts response to midostaurin plus chemotherapy in FLT3 mutant-positive acute myeloid leukemia
Nobre, Luis Veiga, Basanta, Celia Colomina, Pedicona, Salvatore Federico, Dokal, Arran David, Arruda, Andrea, Smith, Ryan, Greenhalgh, Calum, Patella, Francesca, Casado-Izquierdo, Pedro Maria, Wrench, Bela, Theaker, Jane, Thompson, Andrew, Minden, Mark D., Gribben, John G., Britton, David James, Cutillas, Pedro Rodriguez
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article